AnalysisNews

AHCO today

$7.80+$0.08 (+1.04%)close Nov 11, 2026

Trend

DailyUptrend (confirmed)

4 hourStrong Bullish

1 hourStrong Bullish

15 minStrong Bullish

5 minDescending Triangle

Daily trend turns down below $9.75

Key levels

Resistance$10.87

Resistance$9.88

Latest news & SEC filings

AnalystLeerink Partners keeps AdaptHealth at Outperform, lifts price target

AnalystLeerink Partners keeps Outperform on AdaptHealth, lifts target to $8

AnalystRBC notes improved margins on AdaptHealth capitated contracts

All AHCO news →

About AdaptHealth

AdaptHealth supplies home medical equipment, medical supplies, and related services to individuals receiving care where they live. It operates through four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. The company serves Medicare, Medicaid, and commercial insurance beneficiaries across the United States, with referrals from hospitals, sleep labs, physician offices, and other providers.

Based on the company's 10-K filed Feb 24, 2026.

Nasdaq · Healthcare

AdaptHealth Corp. (AHCO)

$7.80+0.08 (+1.04%)
WATCHLISTGrade: BRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
6.046.486.927.367.80Oct 9Oct 19Oct 27Nov 4
High7.92
Low7.64
Open7.65
Volume2.17M
Avg Vol2.47M
VWAP7.79
30d High7.80
30d Low5.60
30d Chg+37.32%

What Is the Price Target for AHCO?

SEPT Low Target

$8.00

SEPT Mid Target

$9.50

SEPT High Target

$16.00

Analyst Consensus

$9.50

Current: $7.80Upside: +21.8%Confidence: 85%Method: Analyst Consensus

Is AHCO a Buy or Sell Right Now?

62
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing -0.5% YoY with SLOWING trend — consistent growth.
  • •Smart money flows are positive — institutional and insider activity shows net buying.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AHCO.

Start Free Trial →

Is AHCO Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B, Analyst Consensus

Fair Value

$13.56

8

Moat Score

NONE

5/9

Piotroski Score

0.8

Altman Z-Score

What Is Smart Money Doing with AHCO?

Insider Signal

BUYING

10 buys / 1 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
CURRIE HARRISS TofficerBuy141,372-Sep 9, 2026
WOLF DALE BdirectorBuy20,000$117KAug 7, 2026
SAMET KENNETH AdirectorBuy23,500$150KAug 6, 2026
WOLF DALE BdirectorBuy20,000$127KAug 6, 2026
Schuster III Russell E.officerSale11,275$113KJun 1, 2026
McFadden Daniel EdwardofficerBuy20,134-May 27, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

AHCO Growth Story

Revenue YoY

-0.5%

3yr Revenue CAGR

3.0%

EPS Growth YoY

-185.25%

FCF Growth YoY

-7.0%

Revenue Trend

SLOWING

Dark Pool Trades for AHCO

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for AHCO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
12:56:26$7.701,000$$8KSELL
21:00:33$7.8023,521$$183KSELL
21:00:32$7.802,200$$17KSELL
21:00:01$7.802,517$$20KSELL
21:00:01$7.808,900$$69KSELL

5 dark pool trades shown · $$297K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

What Traders Are Saying About AHCO

1 posts

SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for AHCO. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

S
Sarah MitchellVERIFIED25d ago

Zone Setup — $AHCO (AdaptHealth Corp.) Price: $6.02 | Zone: $5.86 — $6.24 Conviction: LOW | Analyst upside: +56.8% Near resistance (43% of range) — breakout watch. No recent news — technical setup d...

69 views

Join 3,500+ traders discussing AHCO in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for AdaptHealth Corp. (AHCO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

AHCO — frequently asked questions

What is AHCO stock price today?

AdaptHealth Corp. (AHCO) is at $7.80, up 1.04% (+$0.08) at the Nov 11, 2026 close.

Why is AHCO stock moving today?

Latest AHCO news — Nov 6, 2026: Leerink Partners keeps AdaptHealth at Outperform, lifts price target · Nov 5, 2026: Leerink Partners keeps Outperform on AdaptHealth, lifts target to $8

What is the AHCO price target?

The average analyst price target for AHCO is $9.50, ranging from $8 to $16, based on 6 analysts. Latest: Baird maintains on Sep 17, 2026.

What do analysts rate AHCO?

Analyst ratings for AHCO: 1 Buy, 8 Hold, 0 Sell — consensus Hold.

Did AHCO beat earnings?

AHCO last reported on Nov 3, 2026: EPS -$0.13 vs -$0.05 expected — a miss of 157.4%.

Does AHCO pay a dividend?

AHCO does not currently pay a dividend.

What are AHCO support and resistance levels?

Resistance: $9.88, $10.87.

What are insiders doing with AHCO?

Insider activity: BUYING, 10 buys and 1 sells in the last 90 days.

What is the latest news on AHCO?

Nov 6, 2026: Leerink Partners keeps AdaptHealth at Outperform, lifts price target · Nov 5, 2026: Leerink Partners keeps Outperform on AdaptHealth, lifts target to $8 · Nov 5, 2026: RBC notes improved margins on AdaptHealth capitated contracts